|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash and due from banks | |||||||||||||
| Federal funds sold | |||||||||||||
| Total cash and cash equivalents | |||||||||||||
| Available-for-sale securities, at fair value | |||||||||||||
| Loans held for sale, at fair value | |||||||||||||
| Loans receivable, net of deferred fees | |||||||||||||
| Allowance for credit losses | |||||||||||||
| Net loans | |||||||||||||
| Accrued interest receivable | |||||||||||||
| Banking premises and equipment, net | |||||||||||||
| Depositors Insurance Fund stock | |||||||||||||
| Federal Home Loan Bank stock, at cost | |||||||||||||
| Federal Reserve Bank stock, at cost | |||||||||||||
| Non-public investments | |||||||||||||
| Bank-owned life insurance ("BOLI") | |||||||||||||
| Prepaid expenses and other assets | |||||||||||||
| Goodwill | |||||||||||||
| Core deposit intangible, net | |||||||||||||
| Deferred income tax asset, net | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and shareholders' equity | |||||||||||||
| Deposits | |||||||||||||
| Core deposits | |||||||||||||
| Brokered deposits | |||||||||||||
| Total deposits | |||||||||||||
| Mortgagors' escrow accounts | |||||||||||||
| Federal Home Loan Bank ("FHLB") borrowings | |||||||||||||
| Accrued expenses and other liabilities | |||||||||||||
| Accrued retirement liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Shareholders' equity: | |||||||||||||
| Preferred stock, $0.01 par value, 5,000,000 shares authorized; no shares issued and outstanding | |||||||||||||
| Common stock, $0.01 par value, 120,000,000 shares authorized; 43,818,490 and 45,770,128 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Unallocated common shares held by the Employee Stock Ownership Plan ("ESOP") | |||||||||||||
| Retained earnings | |||||||||||||
| Accumulated other comprehensive loss | |||||||||||||
| Total shareholders' equity | |||||||||||||
| Total liabilities and shareholders' equity | |||||||||||||
Loading...